Actuate Therapeutics Inc
General ticker "ACTU" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $71.4M (TTM average)
Actuate Therapeutics Inc does not follow the US Stock Market performance with the rate: -18.8%.
Estimated limits based on current volatility of 4.0%: low 1.82$, high 1.97$
Factors to consider:
- Total employees count: 200000 as of 2024
- Current price 49.7% below estimated low
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.74$, 9.88$]
- 2026-12-31 to 2027-12-31 estimated range: [3.22$, 8.59$]
Short-term ACTU quotes
Long-term ACTU plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $22.50MM |
| Operating Income | $-22.50MM |
| Non-Operating Income | $0.27MM |
| Interest Expense | $0.02MM |
| R&D Expense | $10.29MM |
| Income(Loss) | $-22.23MM |
| Net Income(Loss)* | $-22.23MM |
| Stockholders Equity | $7.92MM |
| Assets | $14.04MM |
| Operating Cash Flow | $-19.21MM |
| Financing Cash Flow | $23.72MM |
| Earnings Per Share** | $-1.06 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.